So I read the whole report over last night and today and have a few questions and points from what I read...
On page 8. The final approval for the remaining doses of FocXR (5,10,20,40mg). It reads as if the doses cant launch until Teva has their exclusivity window. So are we essentially at their mercy while they try to launch their product? So basically if its 180 days from their launch and they never get around to launching it due to whatever issues they're having do we have to keep waiting? They launched their 40mg dose on November 21st... so its been over 220 days since that dose anyways. Should we not be launching a 40 mg dose by now?
On page 8. So nice news on rexista but what were really waiting for is further news. Most of us know this.
On page 9. Nice news on Regabatin.
They also mention that more money was put towards R&D due to being in a better financial position. My concern here is though that latter on they state the R&D includes stock options and performance bonuses. I'd like to know how much is options and bonuses vs how much went to actual R&D cost. Don't really see that in here. They touch a bit on this on page 15 but says the increase of $1,382,203 covers development cost (which I'm sure we're all ok with) and the payment of bonuses and salary increases.
On page 12. How do warrants change from a liability to equity? Could the earnings been even worse if they didn't?
On page 15. The SGA.. The increases again are to bonuses. Other expenses are down which is nice.
Page 22. They state they're not anticipating generating sufficient cash flow from operations. This concerns me a bit. I was hoping that with the near term possible approvals of the ANDA's that they could generate sufficient cash flow.
On page 23 there was a dilution of 1.85 million shares. Seems fairly Minimal. As of now I think we will continue to see minimal dilution probably from the exercising of warrants and what not. They seem pretty confident that there is enough cash to last till the end of this year.
The convertible debenture maturing on Jan 1st 2015. Any word when the Odi's plan to exercise it? Time is running out and its 500k shares..
Sorry if some of these are stupid questions. I'm Curious
